In March 2025, the company introduced new strategies for any direct-to-shopper offering of its Wegovy weight loss drug. The company proven a fresh pharmacy, named NovoCare, which might cost consumers $499 a month for usage of the drug, lower than 50 % the cost of the drug through other pharmaceutical distribution networks.[fifty three]The subsequen